SEC Form D · filed May 19, 2022
Gilgamesh Pharmaceuticals, Inc
Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.
People & firms on this filing (25)
Andrew Kruegel · New York, NYExec · DirectorRobert Berman · New York, NYDirectorPhil Skolnick · New York, NYDirectorAmy Kruse · New York, NYDirectorJonathan Sporn · New York, NYExec · DirectorGaetano K. Crupi · New York, NYDirectorJulie B. Sanders · Dallas, TXExec · DirectorShawn O'Brien · NOVI, MIDirectorJohn P. Golden · El Segundo, CADirectorMichael S. Downing · West Des Moines, IADirectorEdward Harycki · Bryn Mawr, PAExec · DirectorGerard Marek · New York, NYExecYoni Falkson · New York, NYExecThomas K. Murphy · New York, NYExecLaszlo Kiss · New York, NYExecJames T. Farrell · San Francisco, CAExec · DirectorGaurav Sahni · Short Hills, X1Exec · DirectorChris Wood · Seattle, WADirectorAutum Grimm · Seattle, WADirectorSimon Barnes · Grand Duchy of Luxembourg, LuxembourgDirectorGerard Marek · New York, NYExecYoni Falkson · New York, NYExecThomas K. Murphy · New York, NYExecGaetano K. Crupi · New York, NYDirectorLaszlo Kiss · New York, NYExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗